Model
Edge
CRISPR Therapeutics
0001968317
Filing Type
4
Filing Date
6/2/2025
Updated
6/3/25, 7:45 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership